Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prime boost vaccines power up in people

Nature Medicine volume 9, pages 642–643 (2003)Cite this article

Vaccines using DNA for priming and recombinant modified vaccinia Ankara virus (MVA) for boosting have shown great promise in preclinical models. Now, this novel protocol appears effective in humans (pages 729–735).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. McConkey, S.J. et al. Enhanced T-cell immunogenicity in humans of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara. Nat. Med. 9, 729–735 (2003).

    Article  CAS  Google Scholar 

  2. Schneider, J. et al. Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170, 29–38 (1999).

    Article  CAS  Google Scholar 

  3. Amara, R.R. et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69–74 (2001).

    Article  CAS  Google Scholar 

  4. Shiver, J.W. et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency virus immunity. Nature 415, 331–335 (2002).

    Article  CAS  Google Scholar 

  5. Schneider, J. et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4, 397–402 (1998).

    Article  CAS  Google Scholar 

  6. McShane, H., Brookes, R., Gilbert, S.C. & Hill, A.V. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect. Immun. 69, 681–686 (2001).

    Article  CAS  Google Scholar 

  7. Irvine, K.R. et al. Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. J. Natl. Cancer Inst. 5, 1595–1601 (1997).

    Article  Google Scholar 

  8. Hanke, T. et al. Development of a DNA-MVA/HIVA vaccine for Kenya. Vaccine 20, 1995–1998 (2002).

    Article  CAS  Google Scholar 

  9. Robinson, H.L. New hope for an AIDS vaccine. Nat. Rev. Immunol. 2, 239–250 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The author is at the Emory Vaccine Center and Yerkes National Primate Research Center, 954 Gatewood Drive, Emory University, Atlanta, 30329, Georgia, USA

    Harriet L Robinson

Authors
  1. Harriet L Robinson
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, H. Prime boost vaccines power up in people. Nat Med 9, 642–643 (2003). https://doi.org/10.1038/nm0603-642

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0603-642

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing